Submit Deal
All Dealmakers
Similar Dealmakers
CEO at CORMORANT ASSET MANAGEMENT
Investor
Share Profile
Deal Bio
Market Context
Back to top
All rights reserved. Copyright © 2025 Datasite
Expertise (38)
Key Relationships
Sort
Target: ERASCA
Bidder: ARCH VENTURE PARTNERS
10 Service Providers
22 Dealmakers
£ 161 M
Value
Target: ATEA PHARMACEUTICALS INC
Bidder: ALLY BRIDGE GROUP
15 Service Providers
27 Dealmakers
£ 175 M
Target: GREENLIGHT BIOSCIENCES INC
Bidder: MLS CAPITAL FUND II
11 Service Providers
12 Dealmakers
£ 81 M
Target: I-MAB
Bidder: HILLHOUSE CAPITAL GROUP
18 Service Providers
33 Dealmakers
£ 315 M
Target: VELOSBIO INC
Bidder: CORMORANT ASSET MANAGEMENT
14 Service Providers
16 Dealmakers
£ 105 M
Target: ELEMENT SCIENCE INC
Bidder: THE INVUS GROUP LLC
13 Dealmakers
£ 114 M
Target: BIOATLA
Bidder: SOLEUS CAPITAL
14 Dealmakers
£ 55 M
Target: VECTIVBIO
16 Service Providers
35 Dealmakers
£ 84 M
Target: MIRAGEN THERAPEUTICS
Bidder: VENROCK
19 Dealmakers
£ 70 M
Target: NEUROGENE INC
Bidder: CASDIN CAPITAL
13 Service Providers
£ 85 M
Target: VISEN PHARMACEUTICALS
Bidder: ORBIMED PE
12 Service Providers
£ 111 M
Target: CENTESSA PHARMACEUTICALS
Bidder: JANUS HENDERSON INVESTORS
20 Service Providers
£ 179 M
Target: ARTIVA BIOTHERAPEUTICS
Bidder: ACUTA CAPITAL
n/a
Target: EPIMAB BIOTHERAPEUTICS
Bidder: OCTAGON INVESTMENTS
£ 86 M
Target: TANGO THERAPEUTICS
29 Service Providers
32 Dealmakers
£ 257 M
Target: ICOSAVAX INC
Bidder: SANOFI VENTURES
£ 71 M
Target: GH RESEARCH
Bidder: DEERFIELD MANAGEMENT COMPANY
20 Dealmakers
£ 91 M
Target: ELPISCIENCE BIOPHARMACEUTICAL
10 Dealmakers
£ 74 M
Target: NUMAB THERAPEUTICS
Bidder: NOVO HOLDINGS A/S
11 Dealmakers
£ 78 M
Target: NIKANG THERAPEUTICS
Bidder: SURVEYOR CAPITAL
23 Service Providers
29 Dealmakers
£ 141 M
Target: PRIME MEDICINE
Bidder: T. ROWE PRICE GROUP INC
17 Dealmakers
£ 227 M
Target: UMOJA BIOPHARMA
£ 148 M
Target: STRATA ONCOLOGY
Bidder: BAIRD CAPITAL
£ 64 M
Bidder: XERAYA CAPITAL
17 Service Providers
39 Dealmakers
£ 866 M
Target: SHOUTI
21 Service Providers
£ 72 M
Target: CHROMA MEDICINE
Bidder: ATLAS VENTURE LP
£ 93 M
Target: MOONLAKE IMMUNOTHERAPEUTICS
Bidder: BVF PARTNERS
25 Service Providers
44 Dealmakers
£ 169 M
Target: KORRO BIO
Target: VENTUS THERAPEUTICS
Bidder: ANDREESSEN HOROWITZ LLC (A16Z)
£ 103 M
Target: TESSERA THERAPEUTICS
Bidder: ABU DHABI INVESTMENT AUTHORITY (ADIA)
26 Dealmakers
£ 230 M
Target: MOMA THERAPEUTICS
Bidder: ROCK SPRINGS CAPITAL
£ 121 M
Target: JENAVALVE TECHNOLOGY
Bidder: GIMV NV
9 Service Providers
18 Dealmakers
Target: ENSOMA
Bidder: ARIX BIOSCIENCE
19 Service Providers
£ 108 M
Target: BIVACOR
5 Service Providers
5 Dealmakers
£ 14 M
Target: ONKURE THERAPEUTICS
15 Dealmakers
£ 43 M
Target: ALTRUBIO
£ 177 M
Target: THIRD ARC BIO
Bidder: VIDA VENTURES
£ 127 M
